Evidence map›Paper›PMID 38416787›Full record

ArticlePloS one2024

Study of medium and long-term free flow capacity and queue discharge rates on roads.

Yi Rong, Zitao Xue

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yi RongSchool of Economics and Management, Chang'an University, Xi'an, China.ORCID 0009-0005-3905-8837
Zitao XueR&D Management Department, Honor, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rise in vehicle ownership, traffic congestion has emerged as a major barrier to urban progress, making the study and optimization of urban road capacity exceedingly crucial. The research on the medium and long-term free-flowing capacity and queue emission rate of roads takes an in-depth exploration of this issue from a cutting-edge perspective, aiming to find solutions adaptable to the progression of the times. The purpose of this study is to understand and predict the road capacity and queue emission rate more accurately, thus improving the urban traffic condition. Existing literature primarily focuses on short-term forecasts of road capacity, leaving a notable void in the research of medium and long-term road capacity and queue emission rate. This gap often results in a lack of sufficient foresight when urban traffic planning faces practical issues. To fill this void, this study undertook an in-depth examination of the road capacity and queue emission rate over the medium and long term (10 years) based on big data analysis and artificial intelligence theories. This paper employs a Radial Basis Function (RBF) neural network, combined with twelve other parameters that could potentially impact road capacity, such as traffic volume, road width, number of lanes, traffic signal control methods, etc., to analyze the relationship between each parameter and free-flow traffic and queue emission rate. These analyses are grounded in extensive road data, encompassing not only the city's main roads but also secondary roads and community roads. The study results show a continuous downward trend in the free-flowing capacity of roads and a slight upward trend in the queue emission rate over the past decade. Further analysis reveals the extent of impact each factor has on the free-flow traffic and queue emission rate, providing a scientific basis for future urban traffic planning.

Indexed as

Artificial IntelligencePatient DischargeCity PlanningHumans

Identifiers

PMID38416787
PMCPMC10901346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.